|
|
 |
The centerpiece of UCLA’s hematopathology services is the Clinical Flow Cytometry Outreach program, which provides customized, clinically relevant and timely multiparmetric flow cytometry. Analysis using leading industry standards, in the context of clinico-pathologic correlations identified by our flow cytometrists and nationally recognized multidisciplinary pathologists. Our team of experts are available for consultations, second opinions, and discussion of prognosis and treatment options.
The program includes members with expertise in:
- lymph node and other related tissue interpretation,
- adult and pediatric bone marrow pathology
- Hodgkin’s disease and Non-Hodgkin’s lymphoma
- Leukemia
- Myelodyspasia
- myeloproliferative disorders
- anemia
- immune deficiency and opportunistic infections
|
|
|
|
|
|
|
 |
Gau, C.-L., R.A. Rosenblatt, V. Cerullo, F.D. Lay, A.C. Dow, J. Livesay, N. Brunetti-Pierri, B. Lee, S.D. Cederbaum, W.W. Grody and G. Lipshutz. Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector. Molec. Ther. 2009; 17: 1155-1163. |
|
Rosove, M.H. and W.W. Grody. Should we be applying warfarin pharmacogenetics to clinical practice? No, not now. . Ann. Intern. Med. 2009; 151: 270-273. |
|
Mumenthaler, S.M., H. Yu, S. Tze, S.D. Cederbaum, A.E. Pegg, D.B. Seligson and W.W. Grody. . Differential expression of arginase II in androgen-dependent versus androgen-independent prostate cancer.. Int. J. Oncol. 2008; 32: 357-365. |
|
|
|
|
